Company Overview and News

1
Seven of 10 most valued cos add over Rs 53,799 cr in market cap

9h thehindubusinessline
Seven of the 10 most valued Indian companies together added Rs 53,799.78 crore to their market capitalisation last week, with RIL topping the chart.
500325 KMBKY RELIANCE HINDUNILVR TTNQY MRZUY 532500 532540 HDB MARUTI 500180 RIGD KOTAKBANK 500696 HDFCBANK TCS 500247 RLNIY

0
Reliance Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-07-20 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500325 RELIANCE RIGD RLNIY

0
Reliance Industries hits record high, gains 46% in last one year

2018-07-20 moneycontrol
Reliance Industries' stock price has had a stellar run over the past 12 months and the stock continued its upward journey to touch a record high of Rs 1,122 in morning trade on Friday.
532540 500325 RELIANCE RIGD TCS TTNQY RLNIY

0
RIL m-cap crosses $100-bn mark

2018-07-19 freepressjournal.in
New Delhi : Reliance Industries (RIL) on Thursday crossed the $100-billion market capitalisation-mark in morning trade for the first time in the last 10 years following surge in its share price.
500325 RELIANCE RIGD RLNIY

1
RIL’s market capitalisation breaches Rs 7 lakh-cr mark, India’s 2nd company to achieve the mark after TCS

2018-07-19 freepressjournal.in
New Delhi: The market valuation of Reliance Industries today surged past Rs 7 lakh crore mark in the morning trade, making it the second company after TCS to achieve this milestone.
532540 500325 HDB 500180 RELIANCE RIGD TCS HDFCBANK TTNQY RLNIY

1
Sensex slips from record on profit-booking

2018-07-19 freepressjournal.in
Mumbai: The BSE Sensex retreated from record high to end flat at 36,541.63 today in volatile trade as investors booked profit in recent gainers despite firm global cues.
BAJAJ-AUTO 500325 RELIANCE 532977 BHRQY 533278 532215 500470 AXISBANK RIGD HDFCBANK HEROMOTOCO BHARTIARTL CLNDY RLNIY YESBANK AXB IBN 532648 YYBKY AXBKY 500182 532454 AXBA ICICIBANK TTST TATASTEEL TATLY HDB 532174 500180 HRTQY COALINDIA

10
Reliance Industries chairman Mukesh Ambani topples Alibaba’s Jack Ma to become Asia’s richest person

2018-07-19 freepressjournal.in
Reliance Industries chairman and managing director Mukesh Ambani toppled Alibaba Group’s Jack Ma on Friday to become the richest individual in Asia. According to a report, Ambani’s estimated total wealth hit $44.3 billion on Friday as RIL shares rose 1.6 per cent while Ma’s total net worth stands at $44 billion, according to the report at the close of trade in US on Thursday.
BABA 500325 RELIANCE RIGD RLNIY

0
RJio #39;Monsoon Hungama#39; offer on JioPhone to start from July 20

2018-07-19 moneycontrol
Mukesh Ambani-led Reliance Jio has advanced by a day the launch of its monsoon 'hungama' scheme that would offer its JioPhone to customers for Rs 501 , to July 20, a company source said.
RCOM 500325 RELIANCE RIGD 532712 RLNIY

0
India’s Dirty Secret Is an Oil Market Headache - Bloomberg

2018-07-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
500325 RELIANCE RIGD RLNIY

0
Reliance plans to borrow US$6b in consumer push

2018-07-18 theedgemarkets
MUMBAI (July 18): Reliance Industries Ltd, India’s second-largest company by market value, plans to raise about 400 billion rupees (US$5.8 billion) in fresh debt this financial year as it expands its consumer businesses, according to people familiar with the matter.
RCOM 500325 521070 RELIANCE ALOKTEXT RIGD 532712 RLNIY

0
RIL plans to borrow Rs 40,000 crore in consumer push

2018-07-18 livemint
Mumbai: Reliance Industries Ltd, India’s second-largest company by market value, plans to raise about Rs 40,000 crore in fresh debt this financial year as it expands its consumer businesses, according to people familiar with the matter.
RCOM 500325 521070 RELIANCE ALOKTEXT RIGD 532712 RLNIY

3
For most companies, investors have little say in ratifying auditors

2018-07-18 livemint
Bengaluru: More than half of the 161 companies that have held their annual meetings this year, including Reliance Industries Ltd (RIL) and Tata Steel Ltd, did not seek shareholders’ approval for ratification of auditors.
YESBANK 500325 AXB RELIANCE 532648 YYBKY 532215 AXBKY AXBA WIT 500470 TTST TATASTEEL TATLY HDB AXISBANK 500180 RIGD HDFCBANK RLNIY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to LSE:RIGD / RELIANCE INDUSTRIES on message board site Silicon Investor.

Brigdon Resources - high-growth energy